My biotech business journal watch - year 2003 [ this week | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 ]


General
Patents & intellectual property
Biotech Stocks and Investments
Companies News

 Can't find the biotech business article published in 2003? 
Try a Google search!
Google

General

  1. Howard K. Unlocking the money-making potential of RNAi. Nat Biotechnol. 2003 Dec;21(12):1441-6. [PubMed]
  2. Jia H. Biotech parks proliferate, despite concerns over sustainability. Nat Biotechnol. 2003 Nov;21(11):1259-60. [PubMed]
  3. Sheridan C. Benefits of biotech clusters questioned. Nat Biotechnol. 2003 Nov;21(11):1258-9. [PubMed]
  4. Mazzola L. Commercializing nanotechnology. Nat Biotechnol. 2003 Oct;21(10):1137-43. [PubMed]
  5. Kling J. Roche's microarray tests US FDA's diagnostic policy. Nat Biotechnol. 2003 Sep;21(9):959-60.  [PubMed]
  6. Bradford. TC. Evolving symbiosis—venture capital and biotechnology. Nat Biotechnol. 2003 Sep;21(9):983-4. [PubMed]
  7. Dennis C. Companies vie to put all your genes on a chip. Nature. 2003 Aug 7;424(6949):605. [PubMed]
  8. Goho A. US government previews biotech survey. Nat Biotechnol. 2003 Aug;21(8):837-8. [PubMed]
  9. Jia H. GM labeling in China beset by problems. Nat Biotechnol. 2003 Aug;21(8):835-6. [PubMed]
  10. Webb Walker B, Carty SM. Is the viability of the Lilly doctrine on the decline? Nat Biotechnol. 2003 Aug;21(8):943-4. [PubMed]
  11. Shah J. Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare. Nat Biotechnol. 2003 Jul;21(7):747-753. [PubMed]
  12. Molloy MP. The challenge of industrializing proteomics. Nat Biotechnol. 2003 Jun;21(6):597. [PubMed]
  13. Jacobs T. Hidden in plain view. Nat Biotechnol. 2003 Jun;21(6):603. [PubMed][web supplement]
  14. Lahteenmaki R, DeFrancesco L. Public biotechnology 2002-the numbers. Nat Biotechnol. 2003 Jun;21(6):607-12. [PubMed]
  15. Dibner MD, Trull M, Howell M. US venture capital for biotechnology. Nat Biotechnol. 2003 Jun;21(6):613-7. [PubMed]
  16. Edwards MG, Murray F, Yu R. Value creation and sharing among universities, biotechnology and pharma. Nat Biotechnol. 2003 Jun;21(6):618-24. [PubMed]
  17. Daizadeh I. Integrating intellectual property within the organizational social structure. Nat Biotechnol. 2003 May;21(5):573-5. [PubMed]
  18. Frederickson RM. Biobusiness on the web. Nat Biotechnol. 2003 May;21(5):499-503. [PubMed]
  19. Dove A. Walking the drug regulatory tightrope. Nat Biotechnol. 2003 May;21(5):495-8. [PubMed]
  20. Gatto JG. The changing face of bioinformatics. Drug Discov Today. 2003 May 1;8(9):375-6. [PubMed]
  21. Kalaitzandonakes N, Bijman J. Who is driving biotechnology acceptance? Nat Biotechnol. 2003 Apr;21(4):366-9. [PubMed]
  22. Rubenstein K. Commercial aspects of microarray technology. Biotechniques. 2003 Mar;Suppl:52-4. [PubMed][pdf]
  23. Dove A. Biotech meets NIH to discuss poor disease markets. Nat Med. 2003 Jan; 9:7 [PubMed]

Patents & intellectual property

  1. Kaiser J. Intellectual property. Patent sprawl: from genes to gene interpretation. Science. 2003 Dec 12;302(5652):1878.[PubMed]
  2. Barrett WA. The patent gamble: strategic insights for playing the worldwide patent game. Nat Biotechnol. 2003 Dec;21(12):1515-7.  [PubMed]
  3. Graff GD, Cullen SE, Bradford KJ, Zilberman D, Bennett AB.The public–private structure of intellectual property ownership in agricultural biotechnology. Nat Biotechnol. 2003 Sep;21(9):989-95. [PubMed]
  4. Fox JL. US courts narrow patent exemptions. Nat Biotechnol. 2003 Aug;21(8):834. [PubMed]
  5. Derzko NM, Behringer JW. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents. Nat Biotechnol. 2003 Jul;21(7):823-5. [PubMed]
  6. Stott M, Valentine J. Impact of gene patenting on R&D and commerce. Nat Biotechnol. 2003 Jul;21(7):729-31. [PubMed]
  7. Thomas S. Reply to "Impact of gene patenting on R&D and commerce". Nat Biotechnol. 2003 Jul;21(7):731. [PubMed]
  8. Shuster MJ, Su H, Blaug S. Protecting rights to early-stage technology. Nat Biotechnol. 2003 Jun;21(6):701-3. [PubMed]
  9. Demaine LJ, Fellmeth AX. Patent law. Natural substances and patentable inventions. Science. 2003 May 30;300(5624):1375-6. [PubMed]
  10. Robertson D. US Patent Office strategic plan may penalize biotechs. Nat Biotechnol. 2003 Apr;21(4):345-6. [PubMed]
  11. Warburg RJ, Wellman A, Buck TB, Ligler Schoenhard A. Patentability and maximum protection of intellectual property in proteomics and genomics. Pharmacogenomics. 2003 Jan;4(1):81-90. [PubMed]
  12. Twyman RM, Primrose SB. Techniques patents for SNP genotyping. Pharmacogenomics. 2003 Jan;4(1):67-79. [PubMed]
  13. Vinarov SD. Patent protection for structural genomics-related inventions. J Struct Funct Genomics. 2003;4(2-3):191-209. [PubMed]

Biotech Stocks and Investments

  1. Bouchie A. Companies jostle for access to public markets. Nat Biotechnol. 2003 Dec;21(12):1413-4. [PubMed]
  2. Jacobs T. Biotech IPOs: handle with care. Nat Biotechnol. 2003 Dec;21(12):1437.  [PubMed]
  3. Howell M, Trull M, Dibner MD. The rise of European venture capital for biotechnology. Nat Biotechnol. 2003 Nov;21(11):1287-91. [PubMed]
  4. Jacobs T. Why biotech don't pay dividends - yet. Nat Biotechnol. 2003 Nov;21(11):1283. [PubMed]
  5. Paull R, Wolfe J, Hebert P, Sinkula M. Investing in nanotechnology. Nat Biotechnol. 2003 Oct;21(10):1144-7. [PubMed]
  6. Jacobs T. Going short on biotech. Nat Biotechnol. 2003 Oct;21(10):1133. [PubMed]
  7. Jacobs T. Is Elan a turnaround? Nat Biotechnol. 2003 Sep;21(9):985. [PubMed]
  8. Mitchell P. Biotechs await IPO 'boomlet'. Nat Biotechnol. 2003 Oct;21(10):1116-7. [PubMed]
  9. Mitchell P. Public markets show signs of life. Nat Biotechnol. 2003 Aug;21(8):833-4. [PubMed]
  10. Jacobs T. The stampede to convertibles. Nat Biotechnol. 2003 Aug;21(8):855. [PubMed]
  11. Jacobs T. Another clue to biotech value. Nat Biotechnol. 2003 Jul;21(7):746. [PubMed]
  12. Rasnick D. The biotechnology bubble machine. Nat Biotechnol. 2003 Apr;21(4):355-6. [PubMed]
  13. Jacobs T. Fighting company spin. Nat Biotechnol. 2003 Apr;21(4):357. [PubMed]
  14. Jacobs T. Let the chips fall where they may. Nat Biotechnol. 2003 Feb;21(2):129. [PubMed]
  15. Jacobs T. Who's minding the store? Nat Biotechnol. 2003 Jan;21(1):17. [PubMed]

Companies News

  1. Powell K. Illumina tussles in court with ABI. Nat Biotechnol. 2003 Aug;21(8):836-7. [PubMed]
  2. Whitfield J. DNA-chip firm backs down over upgrade. Nature. 2003 Jul 10;424(6945):119. [PubMed]
  3. Hodgson J. Hyseq-Variagenics merger signals end of the line. Nat Biotechnol. 2003 Jan;21(1):5. [PubMed]
last updated: 20 Dec 2003
home